小鼠模型中CUX1的基因剂量效应破坏造血干细胞稳态并控制骨髓增生异常综合征的严重程度与死亡率
研究利用两种残留CUX1蛋白约54%(Cux1mid)或约12%(Cux1low)的短发夹RNA小鼠模型,发现Cux1mid小鼠发生伴贫血和三系病态造血的骨髓增生异常综合征,Cux1low小鼠发生骨髓增生异常综合征/骨髓增殖性肿瘤和贫血;恢复CUX1表达足以逆转疾病,CUX1敲低骨髓移植受者呈剂量依赖性短暂造血扩增、造血干细胞减少和致死性骨髓衰竭。
要点
- Cux1mid小鼠(残留CUX1蛋白约54%)发生伴贫血和三系病态造血的骨髓增生异常综合征。
- Cux1low小鼠(残留CUX1蛋白约12%)发生骨髓增生异常综合征/骨髓增殖性肿瘤和贫血。
- CUX1敲低骨髓移植受者呈剂量依赖性短暂造血扩增、造血干细胞减少和致死性骨髓衰竭。
核心结论
- 数据支持CUX1敲低促进PI3K信号、驱动造血干细胞退出静息并增殖、导致造血干细胞耗竭的模型。
- 结果证明单个7q基因Cux1的减少足以在小鼠中引起骨髓增生异常综合征。
研究设计与样本
- 研究为基于短发夹RNA的小鼠模型研究,生成残留CUX1蛋白约54%(Cux1mid)或约12%(Cux1low)的两种模型。
- 研究还包括CUX1敲低骨髓移植受者实验,以及人CD34+细胞CUX1敲低后的RNA测序和功能测定。
主要发现
- Cux1mid小鼠发生伴贫血和三系病态造血的骨髓增生异常综合征,Cux1low小鼠发生骨髓增生异常综合征/骨髓增殖性肿瘤和贫血。
- 在患病小鼠中,恢复CUX1表达足以逆转疾病。
- CUX1敲低骨髓移植受者出现短暂造血扩增,随后造血干细胞减少和致死性骨髓衰竭,呈剂量依赖性。
- 人CD34+细胞CUX1敲低后RNA测序鉴定出-7/del(7q)骨髓增生异常综合征基因特征及分化、增殖和磷脂酰肌醇3-激酶(PI3K)信号通路改变。
- 功能测定中CUX1维持造血干细胞静息并抑制增殖;CUX1敲低时PI3K抑制剂Pik3ip1表达降低、PI3K/AKT信号升高。
关键数值与推荐
- Cux1mid小鼠残留CUX1蛋白约54%,Cux1low小鼠残留CUX1蛋白约12%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Monosomy 7 (-7) and del(7q) are high-risk cytogenetic abnormalities common in myeloid malignancies. We previously reported that CUX1, a homeodomain-containing transcription factor encoded on 7q22, is frequently inactivated in myeloid neoplasms, and CUX1 myeloid tumor suppressor activity is conserved from humans to Drosophila. CUX1-inactivating mutations are recurrent in clonal hematopoiesis of indeterminate potential as well as myeloid malignancies, in which they independently carry a poor prognosis. To determine the role for CUX1 in hematopoiesis, we generated 2 short hairpin RNA-based mouse models with ∼54% (Cux1mid) or ∼12% (Cux1low) residual CUX1 protein. Cux1mid mice develop myelodysplastic syndrome (MDS) with anemia and trilineage dysplasia, whereas CUX1low mice developed MDS/myeloproliferative neoplasms and anemia. In diseased mice, restoration of CUX1 expression was sufficient to reverse the disease. CUX1 knockdown bone marrow transplant recipients exhibited a transient hematopoietic expansion, followed by a reduction of hematopoietic stem cells (HSCs), and fatal bone marrow failure, in a dose-dependent manner. RNA-sequencing after CUX1 knockdown in human CD34+ cells identified a -7/del(7q) MDS gene signature and altered differentiation, proliferative, and phosphatidylinositol 3-kinase (PI3K) signaling pathways. In functional assays, CUX1 maintained HSC quiescence and repressed proliferation. These homeostatic changes occurred in parallel with decreased expression of the PI3K inhibitor, Pik3ip1, and elevated PI3K/AKT signaling upon CUX1 knockdown. Our data support a model wherein CUX1 knockdown promotes PI3K signaling, drives HSC exit from quiescence and proliferation, and results in HSC exhaustion. Our results also demonstrate that reduction of a single 7q gene, Cux1, is sufficient to cause MDS in mice.
引用
- An N, Khan S, Imgruet MK, et al. Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS. Blood. 2018. PMID: 29592892. doi:10.1182/blood-2017-10-810028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。